Skip to content
Est. 1998 proudly celebrating our 27th year of championing American business
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Jaguar Health, Inc.

  • SAN FRANCISCO, California
  • Public · NASDAQ: JAGX
  • 47 employees
$2.0MMarket cap
$11.5MRevenue · FY2025
-$53.6MNet income
47Employees
JAGXNASDAQ
2015IPO

About Jaguar Health, Inc.

Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2025
$11.5M
Net income
-$53.6M
Total assets
$38.3M
Market cap
$2.0M

Source: SEC EDGAR · updated Jun 8, 2026

NASDAQ: JAGX

15-minute delayed · data by Polygon.io

Market cap
$2.0M
Open
Day range
Prev close
Volume
IPO date
May 13, 2015

Market data by Polygon.io · prices are 15-minute delayed

No reviews yet. Be the first to review Jaguar Health, Inc..

Write a review
Explore

Similar companies

Browse all →